Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Secondary progressive multiple sclerosis+2

Recruiting

Registered drug

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Teriflunomide

Contact Research Centre

Secondary progressive multiple sclerosis+1

Not yet recruiting

Registered drugNo placebo

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Cyclophosphamide

Contact Research Centre

Secondary progressive multiple sclerosis+2

Not yet recruiting

Registered drug

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Teriflunomide

Contact Research Centre

Secondary progressive multiple sclerosis

Not recruiting

Registered drug

Study on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses

Registered drug

Poland

Participants:18–64 years
Substances:Cladribine

Contact Research Centre

Secondary progressive multiple sclerosis+2

Not recruiting

Registered drugNo placebo

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Secondary progressive multiple sclerosis+4

Not recruiting

Registered drug

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dimethyl Fumarate

Contact Research Centre

Secondary progressive multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Find therapies in clinical trials near you

8 trials match your criteria

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Secondary progressive multiple sclerosis+2

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Secondary progressive multiple sclerosis+1

Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

Secondary progressive multiple sclerosis+2

Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

Secondary progressive multiple sclerosis

Study on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses

Secondary progressive multiple sclerosis+2

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Secondary progressive multiple sclerosis+4

Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

Secondary progressive multiple sclerosis

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.